Literature DB >> 6806380

Limit-dilution analysis of weak influenza-immune T cell responses associated with H-2Kb and H-2Db.

M Allouche, J A Owen, P C Doherty.   

Abstract

A limiting-dilution analysis has been made of influenza-immune cytotoxic T lymphocyte (CTL) response patterns associated with H-2Kb and H-2Dd in the B10.A(5R), and H-2Kk and H-2Db in the B10.A(2R) and B10.A(4R) recombinant mouse strains. In previous in vivo experiments the H-2Kb allele has been shown to be associated with low responsiveness or nonresponsiveness, whereas Db-restricted influenza-specific responses were found to be weak in recombinant strains that possessed the Kk allele. Influenza-immune CTL restricted to the more "dominant" H-2Dd and H-2Kk alleles were found consistently when primed T cells were restimulated in vitro under limiting-dilution conditions. Precursors were present at frequencies of at least twice background levels (lysis of normal targets) in the great majority of experiments, performed with or without added helper factors. The H-2Kb- and H-2Db-restricted responses were much more variable and, for H-2Kb but not for H-2Db, were completely absent when the culture medium did not contain added interleukin preparations. Even so, experiments in which individual microcultures were tested on more than one target demonstrated conclusively both that H-2Kb-restricted CTL can be generated under limiting-dilution conditions and that most, if not all, of these T cells do not cross-react with influenza virus presented in the context of H-2Dd. The characteristics of these "weak" responses are thus that they are more help dependent and show evidence of greater variability between individual mice than the "dominant" CTL clones do.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806380

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Virus-immune T cells and the major histocompatibility complex: evolution of some basic concepts over the past two years.

Authors:  P C Doherty
Journal:  Experientia       Date:  1986-09-15

2.  Induction of Kb-restricted anti-influenza cytotoxic T cells in C57BL mice: importance of stimulator cell type and immunization route.

Authors:  P Pala; B A Askonas
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

3.  HLA-B27, a dominant restricting element in antiviral responses?

Authors:  E Gomard; M Sitbon; A Toubert; B Bègue; J P Lévy
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Recognition of Db and Kb gene products by influenza-specific cytotoxic T cells.

Authors:  A R Townsend; P M Taylor; A L Mellor; B A Askonas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Cross-reactivity patterns of vaccinia-specific cytotoxic T lymphocytes from H-2Kb mutants.

Authors:  J L Hurwitz; S Pan; P J Wettstein; P C Doherty
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Priming of virus-immune memory T cells in newborn mice.

Authors:  D H Schwartz; J L Hurwitz; N S Greenspan; P C Doherty
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  Diversity in the interaction of influenza-A-specific cytotoxic T cells with H-2Kb mutant targets.

Authors:  A R Townsend; P M Taylor; C J Melief; B A Askonas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.

Authors:  M R Bowman; D S Lyles; J W Parce
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

9.  Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice.

Authors:  V J Merluzzi; K Welte; R H Mertelsmann; L Souza; T Boone; K Last-Barney
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

10.  Diminished T-cell response to influenza virus in aged mice.

Authors:  R B Effros; R L Walford
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.